Information about Vascepa (Icosapent ethyl)
Vascepa (Icosapent ethyl) is a prescription medication that contains icosapent ethyl, a purified form of eicosapentaenoic acid (EPA), an omega-3 fatty acid. It is used primarily to reduce elevated triglyceride levels in adults, and it has been shown to lower the risk of cardiovascular events in certain patients. Vascepa is different from traditional omega-3 supplements because it contains highly purified EPA, rather than a mixture of EPA and DHA (another omega-3 fatty acid).
Product Highlights
- Vascepa is prescribed to help lower triglyceride levels in adult patients with severe hypertriglyceridemia (triglyceride levels of 500 mg/dL or higher).
- It is also used to reduce the risk of cardiovascular events, including heart attack, stroke, and the need for procedures to improve blood flow, in patients with established cardiovascular disease or diabetes who also have elevated triglyceride levels.
Key Ingredient
Key Benefits
- Vascepa has been shown to significantly lower triglyceride levels, which can help reduce the risk of developing heart disease.
- Studies have demonstrated that Vascepa can reduce the risk of cardiovascular events, such as heart attack, stroke, and death from heart disease, in high-risk patients.
- Omega-3 fatty acids like EPA have anti-inflammatory effects that may further benefit patients with cardiovascular disease.
- Compared to traditional fish oils, Vascepa has been shown to have fewer side effects and less risk of increasing levels of "bad" LDL cholesterol.
Direction of Use
- Vascepa is taken orally, usually in the form of soft gel capsules.
- The typical recommended dose is 4 grams per day, which may be divided into two doses (e.g., 2 grams twice daily with meals).
- It’s important to follow the prescribed dosing schedule and take Vascepa with food for optimal absorption.
Safety Concerns
- Like other omega-3 fatty acids, Vascepa may increase the risk of bleeding, especially in patients on blood thinners or those with bleeding disorders. It’s important to monitor for signs of unusual bleeding or bruising.
- Some patients may experience mild gastrointestinal symptoms such as indigestion, diarrhea, or a fishy aftertaste.
- Liver function tests should be monitored during treatment, particularly in patients with a history of liver disease.
- Although rare, allergic reactions to Vascepa, including rash or difficulty breathing, can occur.
Avoid Vascepa (Icosapent ethyl) If
- Patients with a known hypersensitivity or allergy to icosapent ethyl, fish, or shellfish should avoid taking Vascepa.
- If you have a bleeding disorder or are taking medications that increase the risk of bleeding (e.g., anticoagulants or antiplatelet drugs), consult your doctor before using Vascepa.
- The safety of Vascepa during pregnancy and breastfeeding has not been fully established, so it should be avoided unless deemed absolutely necessary by a healthcare provider.
- If you have active liver disease or are at risk for liver problems, your healthcare provider will need to evaluate whether Vascepa is safe for you to use.
